Aflac Incorporated $AFL Shares Bought by Signal Advisors Wealth LLC

Signal Advisors Wealth LLC lifted its position in shares of Aflac Incorporated (NYSE:AFL) by 39.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,899 shares of the financial services provider’s stock after acquiring an additional 825 shares during the period. Signal Advisors Wealth LLC’s holdings in Aflac were worth $306,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the business. NorthRock Partners LLC lifted its position in shares of Aflac by 1.5% in the 1st quarter. NorthRock Partners LLC now owns 6,519 shares of the financial services provider’s stock worth $725,000 after buying an additional 95 shares during the last quarter. Valued Wealth Advisors LLC boosted its position in shares of Aflac by 24.4% during the first quarter. Valued Wealth Advisors LLC now owns 495 shares of the financial services provider’s stock worth $55,000 after buying an additional 97 shares during the period. Phillips Wealth Planners LLC grew its stake in shares of Aflac by 1.5% in the first quarter. Phillips Wealth Planners LLC now owns 6,653 shares of the financial services provider’s stock worth $711,000 after purchasing an additional 100 shares in the last quarter. Optas LLC grew its position in Aflac by 3.5% in the 1st quarter. Optas LLC now owns 2,949 shares of the financial services provider’s stock valued at $328,000 after buying an additional 101 shares in the last quarter. Finally, Apexium Financial LP lifted its position in Aflac by 3.4% in the first quarter. Apexium Financial LP now owns 3,103 shares of the financial services provider’s stock worth $345,000 after purchasing an additional 103 shares during the period. Institutional investors own 67.44% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on AFL. Barclays set a $98.00 price objective on shares of Aflac and gave the stock an “underweight” rating in a research note on Monday, July 7th. UBS Group reduced their price target on Aflac from $114.00 to $111.00 and set a “neutral” rating for the company in a research report on Wednesday, August 6th. Raymond James Financial reduced their price objective on shares of Aflac from $115.00 to $110.00 and set an “outperform” rating for the company in a research note on Thursday, May 29th. Morgan Stanley lifted their price objective on Aflac from $108.00 to $113.00 and gave the stock an “equal weight” rating in a research note on Monday, August 18th. Finally, Wall Street Zen raised Aflac from a “sell” rating to a “hold” rating in a report on Saturday, August 9th. Three analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $109.15.

Aflac Stock Performance

Shares of AFL stock opened at $108.01 on Friday. The company’s fifty day simple moving average is $104.68 and its 200-day simple moving average is $105.17. Aflac Incorporated has a 12 month low of $96.95 and a 12 month high of $115.50. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.33. The firm has a market cap of $57.77 billion, a PE ratio of 24.49, a P/E/G ratio of 3.02 and a beta of 0.85.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Tuesday, August 5th. The financial services provider reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.07. The business had revenue of $4.16 billion during the quarter, compared to analysts’ expectations of $4.30 billion. Aflac had a net margin of 15.32% and a return on equity of 15.08%. The business’s revenue was down 19.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.83 EPS. Equities research analysts expect that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 2nd. Investors of record on Wednesday, August 20th were paid a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend was Wednesday, August 20th. Aflac’s dividend payout ratio (DPR) is currently 52.61%.

Aflac declared that its board has authorized a stock buyback program on Tuesday, August 12th that authorizes the company to repurchase 100,000,000 outstanding shares. This repurchase authorization authorizes the financial services provider to repurchase shares of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s management believes its shares are undervalued.

Insider Activity at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the company’s stock in a transaction on Friday, August 8th. The shares were sold at an average price of $102.57, for a total transaction of $102,570.00. Following the transaction, the director owned 25,105 shares in the company, valued at approximately $2,575,019.85. This represents a 3.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.90% of the stock is currently owned by insiders.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.